Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roopa Mehta

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
The Lancet. Diabetes & Endocrinology|September 4, 2021
Insulin therapy development beyond 100 yearsPhilip D Home, Roopa Mehta
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|June 28, 2003
Genetic defects of beta cell function: (MODY) application of molecular biology to clinical medicineFrancisco J Gómez-Pérez, Roopa Mehta
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|February 18, 2014
ABPA Concomitantly Occurring with Invasive Sinus Aspergillosis: A Short Report on Two PatientsSatyawati Mohindra, Roopa Mehta, Amanjit Bal
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 12, 2018
Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK SettingMarc Evans, Roopa Mehta, Jens Gundgaard, et al.
Annals of Medicine|June 24, 2021
Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary careRoopa Mehta, Ronald Goldenberg, Daniel Katselnik, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 16, 2022
Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetesRoopa Mehta, Liana K Billings, Andreas Liebl, et al.
JPMA. the Journal of the Pakistan Medical Association|June 10, 2020
Pandemics of the past: A narrative reviewUzma Khan, Roopa Mehta, Mohammad Ali Arif, et al.
Current Diabetes Reports|March 28, 2012
Evidence-based medicine and the selection of lipid-lowering therapy in type 2 diabetesCarlos A Aguilar-Salinas, Roopa Mehta, Rita A Gomez-Diaz
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|January 13, 2011
[Epidemiology of diabetes in the elderly]Roopa Mehta, María Eugenia del-Moral, Carlos Alberto Aguilar-Salinas
Lancet (London, England)|June 8, 2026
Epidemiology of cardiometabolic multiple long-term conditionsKamlesh Khunti, Francesco Zaccardi, Roopa Mehta, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
The Lancet. Diabetes & Endocrinology|September 4, 2021
Insulin therapy development beyond 100 yearsPhilip D Home, Roopa Mehta
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|June 28, 2003
Genetic defects of beta cell function: (MODY) application of molecular biology to clinical medicineFrancisco J Gómez-Pérez, Roopa Mehta
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|February 18, 2014
ABPA Concomitantly Occurring with Invasive Sinus Aspergillosis: A Short Report on Two PatientsSatyawati Mohindra, Roopa Mehta, Amanjit Bal
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 12, 2018
Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK SettingMarc Evans, Roopa Mehta, Jens Gundgaard, et al.
Annals of Medicine|June 24, 2021
Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary careRoopa Mehta, Ronald Goldenberg, Daniel Katselnik, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 16, 2022
Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetesRoopa Mehta, Liana K Billings, Andreas Liebl, et al.
JPMA. the Journal of the Pakistan Medical Association|June 10, 2020
Pandemics of the past: A narrative reviewUzma Khan, Roopa Mehta, Mohammad Ali Arif, et al.
Current Diabetes Reports|March 28, 2012
Evidence-based medicine and the selection of lipid-lowering therapy in type 2 diabetesCarlos A Aguilar-Salinas, Roopa Mehta, Rita A Gomez-Diaz
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|January 13, 2011
[Epidemiology of diabetes in the elderly]Roopa Mehta, María Eugenia del-Moral, Carlos Alberto Aguilar-Salinas
Lancet (London, England)|June 8, 2026
Epidemiology of cardiometabolic multiple long-term conditionsKamlesh Khunti, Francesco Zaccardi, Roopa Mehta, et al.
Pageof 11